April 17, 2018
Novo Nordisk Japan President Ole Moelskov Bech Danish diabetes powerhouse Novo Nordisk A/S saw its Japan sales inch up 0.2% year on year to 91.6 billion yen in 2017, squeaking out another record as its long-acting insulin analog Tresiba (insulin...read more